BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Harvard Business School
US Department of Justice
Johnson and Johnson

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021627

« Back to Dashboard
NDA 021627 describes NAMENDA, which is a drug marketed by Forest Labs Llc and is included in three NDAs. It is available from seven suppliers. There are seven patents protecting this drug and five Paragraph IV challenges. Additional details are available on the NAMENDA profile page.

The generic ingredient in NAMENDA is memantine hydrochloride. There are twenty-eight drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the memantine hydrochloride profile page.

Summary for NDA: 021627

Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021627

Mechanism of ActionNMDA Receptor Antagonists

Suppliers and Packaging for NDA: 021627

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
memantine hydrochloride
SOLUTION;ORAL 021627 NDA Forest Laboratories, Inc. 0456-3202 0456-3202-12 360 mL in 1 BOTTLE (0456-3202-12)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength2MG/ML
Approval Date:Apr 18, 2005TE:AARLD:Yes

Expired Orange Book Patents for NDA: 021627

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Llc
memantine hydrochloride
SOLUTION;ORAL021627-001Apr 18, 2005► Subscribe► Subscribe
Forest Labs Llc
memantine hydrochloride
SOLUTION;ORAL021627-001Apr 18, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
Daiichi Sankyo
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus